This is a preview of subscription content, log in via an institution to check access.
References
Nichol KL, Mendelman PM, Mallon KP, Live Attenuated Influenza Virus Vaccine in Healthy Adults Trial Group, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999 Jul 14; 282: 137–44
Jackson LA, Holmes SJ, Mendelman PM, et al. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist (TM), administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine 1999 Apr 9; 17: 1905–9
Clements ML, Makhene MK, Karron RA, et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J Infect Dis 1996 Jan; 173: 44–51
Gorse GJ, Otto EE, Powers DC, et al. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J Infect Dis 1996 Feb; 173: 285–90
King Jr JC, Lagos R, Bernstein DI, et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis 1998 May; 177: 1394–7
Gruber W, Belshe R, Mendelman P, et al. Immunologic response to heterotypic H3N2 strains after live intranasal or inactivated intramuscular influenza vaccine in children. Clin Infect Dis 1998 Oct; 27: 933
Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998 May 14; 338: 1405–12
Rights and permissions
About this article
Cite this article
Influenza Virus Vaccine Live Intranasal (Aviron). Drugs R&D 2, 204–207 (1999). https://doi.org/10.2165/00126839-199902030-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199902030-00013